High frequency of mutations of the PIK3CA gene in human cancers
about
Gene expression profiling reveals new aspects of PIK3CA mutation in ERalpha-positive breast cancer: major implication of the Wnt signaling pathwayAck1 mediated AKT/PKB tyrosine 176 phosphorylation regulates its activationMain roads to melanomaMutations of PIK3CA in gastric adenocarcinomaMutational profiling of kinases in glioblastoma.PI-3 kinase activity is necessary for ERK1/2-induced disruption of mammary epithelial architecture.Prognostic Role of PIK3CA Mutation in Colorectal Cancer: Cohort Study and Literature ReviewAkt phosphorylates and suppresses the transactivation of retinoic acid receptor alphaSecond AKT: the rise of SGK in cancer signallingShould individual PI3 kinase isoforms be targeted in cancer?Unbiased screening for transcriptional targets of ZKSCAN3 identifies integrin beta 4 and vascular endothelial growth factor as downstream targetsGain of interaction with IRS1 by p110α-helical domain mutants is crucial for their oncogenic functionsMarkers of resistance to anti-EGFR therapy in colorectal cancerA pharmacological map of the PI3-K family defines a role for p110alpha in insulin signalingAnalysis of the genome to personalize therapy for melanomaProtein kinases and phosphatases in the control of cell fateSomatic mosaic activating mutations in PIK3CA cause CLOVES syndromeMolecular biology of lung cancer: clinical implicationsRetroviral oncogenes: a historical primerInternational network of cancer genome projects.Molecular origins of cancer: Molecular basis of colorectal cancerPushing the envelope in the mTOR pathway: the second generation of inhibitorsDe novo germline and postzygotic mutations in AKT3, PIK3R2 and PIK3CA cause a spectrum of related megalencephaly syndromesLoss of PHLPP expression in colon cancer: role in proliferation and tumorigenesisThe PI3K pathway as drug target in human cancerMosaic overgrowth with fibroadipose hyperplasia is caused by somatic activating mutations in PIK3CAEmerging common themes in regulation of PIKKs and PI3KsPotential therapeutic targets for chordoma: PI3K/AKT/TSC1/TSC2/mTOR pathwayAn integrated genomic analysis of human glioblastoma multiformeTumours with PI3K activation are resistant to dietary restrictionWhole-genome cancer analysis as an approach to deeper understanding of tumour biologyComprehensive genomic characterization defines human glioblastoma genes and core pathwaysBrick by brick: metabolism and tumor cell growthKnockin of mutant PIK3CA activates multiple oncogenic pathwaysThe noncoding RNA, miR-126, suppresses the growth of neoplastic cells by targeting phosphatidylinositol 3-kinase signaling and is frequently lost in colon cancersNew molecularly targeted therapies for lung cancerTransforming properties of YAP, a candidate oncogene on the chromosome 11q22 ampliconMucinous differentiation correlates with absence of EGFR mutation and presence of KRAS mutation in lung adenocarcinomas with bronchioloalveolar featuresNew targets for therapy in breast cancer: mammalian target of rapamycin (mTOR) antagonistsA simplified immunoprecipitation method for quantitatively measuring antibody responses in clinical sera samples by using mammalian-produced Renilla luciferase-antigen fusion proteins
P2860
Q21135589-EFD35962-39E2-41AB-909B-860732387684Q21142629-A5E27553-F0C8-4A8A-9FB2-360189C1B908Q21245465-6985A27F-489E-47A8-BC87-C8B4812E3B32Q21261219-0F7C44DE-CD16-48B4-89D6-5A4FB5A95435Q21261249-5C7CE385-F5DC-48D3-BB3B-906D30B9C5C1Q22000770-B9660A0E-443D-447B-B8E8-9D0F908052FAQ24289005-73757597-81C2-4524-9CB3-53627995F68BQ24301372-A5AA84F6-C46F-4496-8DF9-FBA6F9E49767Q24301817-C4ADC04D-FFAD-4B79-99CB-3D6C05C1AD0FQ24309044-998D3C2D-06DA-4702-97EC-4BD45E60BF4DQ24336689-6DD61543-A793-4454-A134-837C50F9BD11Q24339544-452936FC-AE9B-46D9-866E-87910C6B7CA6Q24598640-3BE70EB4-6E5B-4F8B-A442-E5C1B304F1D9Q24599676-40EAF27C-9927-4473-94F7-21FDBDE8EACEQ24601008-360F6937-163F-4259-9F54-2E3565FFB3CAQ24604987-BFDF3F95-F466-4F4B-9399-D34CB5AE4AB8Q24608709-28BE98B5-2B8E-43D6-9AF1-1EC17C95079EQ24610335-188E19AD-6657-4FBC-98A3-3C97632B7A68Q24611142-44074671-A42E-4C86-BFC0-B957FF6D0BC8Q24611474-EE5CC03D-EFAE-440D-B467-2B13A6279C20Q24617331-2A7E4EEF-E29C-4765-B2B5-474C6BC949D9Q24622222-F1B1552E-1938-42BF-BFB2-9B063B4C8AD4Q24627067-43CD805B-8A4D-42D0-BF4C-AA4D3263EDC0Q24632198-94E68192-FF2B-4AA7-9760-6D6E0494A799Q24632283-D0B0E191-4682-483B-A11C-C782C9A8890FQ24632718-319D1C8F-2B20-4B2A-9CF0-7C0EE90466A5Q24647293-297DDA8D-BB83-4EE0-985D-4500E8957D53Q24648029-FF4D04CB-5D00-4702-A3C2-AB9414105D5FQ24648860-2B1708F2-521B-4D86-8519-3DFA7F454077Q24650286-327639CD-C12F-483C-8A64-C8820AB11221Q24653972-20BFCFD9-9471-46C4-948A-B8BA8CC5D49AQ24656128-B960EC6A-CFF5-431D-8333-21D00D99FA6DQ24656187-769A7217-26DF-4589-8E48-AD20D9388284Q24657412-984456E7-029D-4885-B013-CECD601EF6E5Q24658079-4BDDA9D6-03FE-49C6-9EB6-9979DE3076D9Q24680988-87F597DD-7115-4D4A-98C7-3FDED22D38E8Q24682018-7277E61D-1D18-45B8-96EB-26AD9C178212Q24683814-A8140D87-374E-4347-A859-29F9A7823DE3Q24806542-4369688A-2F2E-43E4-A8EA-A1D2E864AB6CQ24813048-88B452C9-F4B0-4F4E-905B-8267F94938CC
P2860
High frequency of mutations of the PIK3CA gene in human cancers
description
2004 nî lūn-bûn
@nan
2004 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
High frequency of mutations of the PIK3CA gene in human cancers
@ast
High frequency of mutations of the PIK3CA gene in human cancers
@en
High frequency of mutations of the PIK3CA gene in human cancers
@nl
type
label
High frequency of mutations of the PIK3CA gene in human cancers
@ast
High frequency of mutations of the PIK3CA gene in human cancers
@en
High frequency of mutations of the PIK3CA gene in human cancers
@nl
prefLabel
High frequency of mutations of the PIK3CA gene in human cancers
@ast
High frequency of mutations of the PIK3CA gene in human cancers
@en
High frequency of mutations of the PIK3CA gene in human cancers
@nl
P2093
P50
P3181
P356
P1433
P1476
High frequency of mutations of the PIK3CA gene in human cancers
@en
P2093
Adi Gazdar
Gregory J Riggins
James K V Willson
Janine Ptak
Natalie Silliman
Sanford Markowitz
Steve Szabo
Steven M Powell
Zhenghe Wang
P3181
P356
10.1126/SCIENCE.1096502
P407
P577
2004-04-23T00:00:00Z